#AIEye #Podcast 695: #Stocks discussed: (ASX:BRN) (TSX: $DTOL.TO) #artificialintelligence

 

 

#AIEye #Podcast 695: #Stocks discussed: (ASX:BRN) (TSX: $DTOL.TO) #artificialintelligence

 

BrainChip Partners with Edge Impulse, and D2L Expands Use of AI Tech

 

Global #AI in #Pharma to Reach $7.14B by 2029

 

Vancouver, Kelowna, Delta, BC – May 16, 2022  – Investorideas.com, a global investor news source covering Artificial Intelligence (AI) brings you today’s edition of  The AI Eye-watching stock news, deal tracker and advancements in artificial intelligence.

 

Listen to today’s podcast:

https://www.investorideas.com/Audio/Podcasts/2022/051622-AI-Eye.mp3

 

Read this in full at https://www.investorideas.com/news/2022/artificial-intelligence/05161BRN-DTOL.asp

 

Hear the Ai Eye on Spotify  

 

Today’s Column- The AI Eye- Watching stock news, deal tracker and advancements in artificial intelligence

 

Stocks discussed: (ASX:BRN) (TSX:DTOL)

 

BrainChip Holdings Ltd. (ASX:BRN) and Edge Impulse, a development platform for machine learning (ML) on edge devices, are partnering to deliver next-generation platforms to customers looking to develop products utilizing the companies' machine learning capabilities. Jerome Nadel, BrainChip’s CMO, said:

 

"Partnering with Edge Impulse creates a unique market solution that brings their powerful and easy to use AI/ML application design platform unparalleled performance with BrainChip's silicon proven on-chip learning and ultra-low power IP. We continue to look for partnerships that will advance opportunities to enable a wide array of edge AI capabilities, such as continuous learning and real-time inference. Edge Impulse is a perfect addition to our ecosystem of providers enabling next-generation technology to markets around the world."

 

Global learning technology company D2L Inc. (TSX:DTOL) has announced an expansion in its use of intelligent technology, including artificial intelligence, smart workflow design, and automation, to “help educators personalize learning.” John Baker, President and CEO of D2L, said:

 

“For more than a decade, D2L has been at the forefront of building intelligent tools within our products to make it easier to build engaging experiences and get the right feedback to learners when they need it the most. Personalizing learning is not easy, and our goal with intelligent tools is to help instructors save time, so they can focus on what really matters: improving outcomes for their learners.”

 

 

Global AI in Pharma to Reach $7.14B by 2029

 

A report published by Polaris Market Research finds that the global AI in Pharmaceutical market is projected to grow from $859.1 million USD in 2021 to $7.14 billion in 2029, registering a compound annual growth rate (CAGR) fo 31.2 percent in the forecast period 2022-29. The following excerpt from the report’s description outlines the ways in which AI is being leveraged in the market:

 

Drug discovery, smart manufacturing, automated control processes systems, the prediction of new treatments, and the production of novel peptides from natural foods raise awareness for the use of AI in pharma.

 

Furthermore, pharma companies present across the global market are using advanced machine learning algorithms and AI-powered tools to speed up the drug discovery process. These technologies are designed to detect complex patterns in vast datasets and may thus solve problems related to complex biological networks.

 

Sam Mowers, Investorideas.com

 

Read and hear other editions of the AI  Eye

 

For a list of artificial intelligence stocks on Investorideas.com visit here

 

About Investorideas.com - News that Inspires Big Investing Ideas

Investorideas.com publishes breaking stock news, third party stock research, guest posts and original articles and podcasts in leading stock sectors.  Learn about investing in stocks and get investor ideas in cannabis, crypto, AI and IoT, mining, sports biotech, water, renewable energy, gaming and more. Investor Idea’s original branded content includes podcasts and columns : Crypto Corner , Play by Play sports and stock news , Investor Ideas Potcasts Cannabis News and Stocks on the Move podcast ,  Cleantech and Climate Change , Exploring Mining , Betting on Gaming Stocks Podcast and  the AI Eye Podcast.

 

The Investorideas.com podcasts are also available on Apple Podcasts ,  Audible , Spotify, Tunein, Stitcher, Spreaker.com, iHeartRadio, Google Podcasts  and most audio platforms available.

Visit the Podcast page at Investorideas.com: https://www.investorideas.com/Audio/

 

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

 

The AI Eye-  Watching stock news, deal tracker and  advancements in artificial intelligence is an original content brand of Investorideas.com

 

Follow us on Twitter https://twitter.com/Investorideas

Follow us on Facebook https://www.facebook.com/Investorideas

Follow us on YouTube https://www.youtube.com/c/Investorideas

 

Contact Investorideas.com

800 665 0411 

Get more Technology stock investor ideas - news, articles, podcasts and stock directories

 

#AIEye #Podcast 694: #Stocks discussed: (ASX:BRN) (TSXV: $NXO.V) #artificialintelligence

 

 

#AIEye #Podcast 694: #Stocks discussed: (ASX:BRN) (TSXV: $NXO.V) #artificialintelligence

 

BrainChip Announces AI Enablement Program, and NexOptic’s ALIIS AI Selected by Semicon Networks for Auto-Pilot Systems

 

Global #AI in #MedicalImaging Market to Reach $20.11B by 2031

 

Vancouver, Kelowna, Delta, BC – May 13, 2022  – Investorideas.com, a global investor news source covering Artificial Intelligence (AI) brings you today’s edition of  The AI Eye-watching stock news, deal tracker and advancements in artificial intelligence.

 

Listen to today’s podcast:

https://www.investorideas.com/Audio/Podcasts/2022/051322-AI-Eye.mp3

 

Read this in full at https://www.investorideas.com/news/2022/artificial-intelligence/05131BRN-NXO.asp

 

Hear the Ai Eye on Spotify  

 

Today’s Column- The AI Eye- Watching stock news, deal tracker and advancements in artificial intelligence

 

Stocks discussed: (ASX:BRN) (TSXV:NXO)

 

BrainChip Holdings Ltd. (ASX:BRN) has announced a three-tier AI Enablement Program to support customers seeking to deploy edge AI/ML to improve and differentiate their products. According to the press release, the Program “delivers working prototypes that demonstrate on-chip, in device AI inference and learning,” providing “turn-key support, from collaborative identification of device AI use cases to sensor and model integration, running on Akida hardware.” Sean Hehir, BrainChip’s CEO, said:

 

"BrainChip's AI Enablement Program ensures a simple, singular path to excellence in deploying edge AI/ML so our customers can overcome barriers and accelerate time to market. The program's three distinct options for design, development and support levels meet the needs of organizations developing next-generation products, from prototype to production."

 

NexOptic Technology Corp. (TSXV:NXO) has announced that its ALIIS AI has been selected by Semicon Networks of South Korea to bring safer vision solutions to automotive auto-pilot systems. ALIIS is described in the press release as “a machine-learning AI suite providing significant instant energy savings, advanced data compression and enhancements to images and videos everywhere from the edge to the cloud.” Richard Geruson, Chairman of NexOptic, said:

 

“Auto-pilot technologies bring exciting opportunities for AI companies like NexOptic. AI based object recognition is a critical component of these systems, and being able to perform effectively at night, in inclement weather conditions and in other challenging environments will be key to any company wanting to succeed in this rapidly evolving industry.”

 

 

Global AI in Medical Imaging Market to Reach $20.11B by 2031

 

A report published by Transparency Market Research finds that the global AI in Medical Imaging market is projected to reach $20.11 billion USD by 2031, registering a compound annual growth rate (CAGR) of 36.1 percent in the forecast period 2021-31. The following excerpt from the report’s summary outlines the ways in which AI is being leveraged in the market:

 

The application of artificial intelligence (AI) in medical imaging is one of the most promising areas of health and medical innovation. Certainly, AI finds various applications in medical imaging such as image acquisition, processing to aided reporting, follow-up planning, data storage, data mining, and others. In recent years, AI has shown remarkable precision and sensitivity in the classification of imaging abnormalities and ensures to improve tissue-based detection and characterization.

 

Sam Mowers, Investorideas.com

 

Read and hear other editions of the AI  Eye

 

For a list of artificial intelligence stocks on Investorideas.com visit here

 

About Investorideas.com - News that Inspires Big Investing Ideas

Investorideas.com publishes breaking stock news, third party stock research, guest posts and original articles and podcasts in leading stock sectors.  Learn about investing in stocks and get investor ideas in cannabis, crypto, AI and IoT, mining, sports biotech, water, renewable energy, gaming and more. Investor Idea’s original branded content includes podcasts and columns : Crypto Corner , Play by Play sports and stock news , Investor Ideas Potcasts Cannabis News and Stocks on the Move podcast ,  Cleantech and Climate Change , Exploring Mining , Betting on Gaming Stocks Podcast and  the AI Eye Podcast.

 

The Investorideas.com podcasts are also available on Apple Podcasts ,  Audible , Spotify, Tunein, Stitcher, Spreaker.com, iHeartRadio, Google Podcasts  and most audio platforms available.

Visit the Podcast page at Investorideas.com: https://www.investorideas.com/Audio/

 

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

 

The AI Eye-  Watching stock news, deal tracker and  advancements in artificial intelligence is an original content brand of Investorideas.com

 

Follow us on Twitter https://twitter.com/Investorideas

Follow us on Facebook https://www.facebook.com/Investorideas

Follow us on YouTube https://www.youtube.com/c/Investorideas

 

Contact Investorideas.com

800 665 0411 

Get more Technology stock investor ideas - news, articles, podcasts and stock directories

 

#AIEye #Podcast 693: #Stocks discussed: (OTCPINK: $GTCH) (NYSE: $ZBH) #artificialintelligence

 

 

#AIEye #Podcast 693: #Stocks discussed: (OTCPINK: $GTCH) (NYSE: $ZBH) #artificialintelligence

 

GBT to Further Broaden Innovative IC Design, and Zimmer Biomet Adds New AI Capabilities to Omni Suite

 

Global #AI in #Pharma Market to Reach $3.62B by 2026

 

Vancouver, Kelowna, Delta, BC – May 11, 2022  – Investorideas.com, a global investor news source covering Artificial Intelligence (AI) brings you today’s edition of  The AI Eye-watching stock news, deal tracker and advancements in artificial intelligence – featuring technology company GBT Technologies Inc. (OTCPINK:GTCH).

 

Listen to today’s podcast:

https://www.investorideas.com/Audio/Podcasts/2022/051122-AI-Eye.mp3

 

Read this in full at https://www.investorideas.com/news/2022/artificial-intelligence/05111GTCH-ZBH.asp

 

Hear the Ai Eye on Spotify  

 

Today’s Column- The AI Eye- Watching stock news, deal tracker and advancements in artificial intelligence

 

Stocks discussed: (OTCPINK:GTCH) (NYSE:ZBH)

 

GBT Technologies Inc. (OTC PINK:GTCH) has announced that it will be further broadening its 3D, multiplanar, integrated circuits design and manufacturing continuation patent application. The press release indicates that the invention could be a significant development, “particularly for integrated circuits that require vast amounts of silicon space like memories, CPU, GPU and AI.” The company’s CTO, Danny Rittman, explained:

 

“We believe this is an innovative concept, designed to be accompanied with scaling down ICs size to fit into smaller electronic devices. Redesigning and manufacturing microchips with multiplanetary architecture would enable placing more circuitries on same or smaller space silicon dies, which would expect to significantly lower their cost. The 3D microchip continuation application is planned to broaden the original patent with design and fabrication concepts. With the ever-growing microchip's complexity, demand for less power, faster performance and smaller size, we believe that the presented patent's technology can be an efficient solution, enabling economical IC's design and manufacturing, creating new horizons and standards.”

 

Zimmer Biomet Holdings, Inc. (NYSE:ZBH) has introduced new artificial intelligence (AI) capabilities within the Omni Suite, described in the press release as “an intelligent operating room (OR) designed to optimize surgical workflow and procedural efficiency.” The new AI feature “uses cameras to automatically recognize and timestamp key OR workflow milestones,” and “further expands the AI capabilities of ZBEdge, a suite of integrated smart, digital and robotic technologies designed to deliver transformative data-powered clinical insights with the goal of improving patient outcomes.” Zimmer Biomet’s COO, Ivan Tornos, said:

 

"Omni Suite's latest feature further enhances the value and utility of the Omni Suite platform while adding AI capabilities to strengthen our ZBEdge Connected Intelligence Suite. Omni Suite, along with the smart, digital and robotic solutions that make up ZBEdge, allow us to create value innovation that unlocks data-driven insights to enhance the surgical experience for surgeons, care teams and patients."

 

Global AI in Pharma Market to Reach $3.62B by 2026

 

A report published by Research and Markets finds that the global market for AI in Pharma is projected to grow from $1.23 billion USD in 2022 to $3.62 billion in 2026, registering a compound annual growth rate (CAGR) of 30.9 percent in the forecast period. The following excerpt from the report’s summary outlines the role of AI in clinical trials as a key market driver:

 

The growing adoption of artificial intelligence (AI) for clinical trials research is driving its demand for AI in the pharmaceutical market. To bring a new drug to the market takes on average 10–15 years approximately and half of this time is consumed during the clinical trial phases of the drug development cycle. Hence, using AI models and analytics tools can accelerate the clinical trial phases, perception of diseases, identify suitable cases and key investigators to inform site selection, and support novel clinical study designs.

 

Sam Mowers, Investorideas.com

 

Read and hear other editions of the AI  Eye

 

For a list of artificial intelligence stocks on Investorideas.com visit here

 

About GBT Technologies Inc.

GBT Technologies, Inc. (OTC PINK: GTCH) (“GBT”) (http://gbtti.com) is a development stage company which considers itself a native of Internet of Things (IoT), Artificial Intelligence (AI) and Enabled Mobile Technology Platforms used to increase IC performance. GBT has assembled a team with extensive technology expertise and is building an intellectual property portfolio consisting of many patents. GBT’s mission, to license the technology and IP to synergetic partners in the areas of hardware and software. Once commercialized, it is GBT’s goal to have a suite of products including smart microchips, AI, encryption, Blockchain, IC design, mobile security applications, database management protocols, with tracking and supporting cloud software (without the need for GPS). GBT envisions this system as a creation of a global mesh network using advanced nodes and super performing new generation IC technology. The core of the system will be its advanced microchip technology; technology that can be installed in any mobile or fixed device worldwide. GBT’s vision is to produce this system as a low cost, secure, private-mesh-network between any and all enabled devices. Thus, providing shared processing, advanced mobile database management and sharing while using these enhanced mobile features as an alternative to traditional carrier services.

 

About Investorideas.com - News that Inspires Big Investing Ideas

Investorideas.com publishes breaking stock news, third party stock research, guest posts and original articles and podcasts in leading stock sectors.  Learn about investing in stocks and get investor ideas in cannabis, crypto, AI and IoT, mining, sports biotech, water, renewable energy, gaming and more. Investor Idea’s original branded content includes podcasts and columns : Crypto Corner , Play by Play sports and stock news , Investor Ideas Potcasts Cannabis News and Stocks on the Move podcast ,  Cleantech and Climate Change , Exploring Mining , Betting on Gaming Stocks Podcast and  the AI Eye Podcast.

 

The Investorideas.com podcasts are also available on Apple Podcasts ,  Audible , Spotify, Tunein, Stitcher, Spreaker.com, iHeartRadio, Google Podcasts  and most audio platforms available.

Visit the Podcast page at Investorideas.com: https://www.investorideas.com/Audio/

 

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions.

Disclosure: GTCH is a paid featured AI stock More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

The AI Eye-  Watching stock news, deal tracker and  advancements in artificial intelligence is an original content brand of Investorideas.com

 

Follow us on Twitter https://twitter.com/Investorideas

Follow us on Facebook https://www.facebook.com/Investorideas

Follow us on YouTube https://www.youtube.com/c/Investorideas

 

Contact Investorideas.com

800 665 0411 

Get more Technology stock investor ideas - news, articles, podcasts and stock directories